Robert W. Shafer mostly deals with Virology, Drug resistance, Reverse transcriptase, Genetics and Immunology. His study in Virus, Zidovudine, Reverse-transcriptase inhibitor, Didanosine and Lamivudine falls within the category of Virology. His study in Drug resistance is interdisciplinary in nature, drawing from both Mutation, Viral disease, Protease, HIV drug resistance and Genotype.
His work in Reverse transcriptase addresses issues such as Multiple drug resistance, which are connected to fields such as Mutagenesis. His work deals with themes such as Computational biology and Genetic diversity, which intersect with Genetics. The concepts of his Immunology study are interwoven with issues in Randomized controlled trial and Genome-wide association study.
Virology, Drug resistance, Genetics, Reverse transcriptase and Virus are his primary areas of study. His Virology study combines topics in areas such as Mutation, Protease and Genotype. His Drug resistance study integrates concerns from other disciplines, such as Regimen, Acquired immunodeficiency syndrome, Immunology, HIV drug resistance and Resistance mutation.
His Immunology research is multidisciplinary, relying on both Internal medicine and Drug. Robert W. Shafer combines subjects such as Molecular biology, Nucleic acid sequence and Zidovudine with his study of Reverse transcriptase. The study incorporates disciplines such as RNA, Nucleotidyltransferase and Polymerase chain reaction in addition to Virus.
His main research concerns Drug resistance, Virology, Mutation, HIV drug resistance and Antiretroviral therapy. The Drug resistance study combines topics in areas such as Integrase, Regimen, Reverse transcriptase and Intensive care medicine. His Virology study incorporates themes from Polymerase, Clinical trial, Integrase inhibitor, Genotype and Monoclonal antibody.
To a larger extent, he studies Genetics with the aim of understanding Mutation. His Genetics study often links to related topics such as Protease. As a part of the same scientific family, he mostly works in the field of HIV drug resistance, focusing on Epidemiology and, on occasion, Incidence.
Robert W. Shafer mainly focuses on Drug resistance, Virology, Reverse transcriptase, Regimen and Intensive care medicine. The various areas that Robert W. Shafer examines in his Drug resistance study include Mutation, Acquired immunodeficiency syndrome, Reverse-transcriptase inhibitor, Transmission and HIV drug resistance. His Mutation study is related to the wider topic of Genetics.
His Virology research is multidisciplinary, relying on both Genotypic resistance and Genotype. He interconnects Sanger sequencing, Molecular epidemiology, Integrase and Odds ratio in the investigation of issues within Reverse transcriptase. His Internal medicine research incorporates elements of Treatment as prevention and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
Science (2010)
2011 update of the drug resistance mutations in HIV-1.
Johnson Va;Calvez;Günthard Hf;Paredes R.
Topics in antiviral medicine (2011)
Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes.
PLOS ONE (2009)
Human immunodeficiency virus reverse transcriptase and protease sequence database
Robert W. Shafer;Derek Stevenson;Bryan Chan.
Nucleic Acids Research (1999)
2017 Update of the Drug Resistance Mutations in HIV-1.
Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2016)
2015 Update of the Drug Resistance Mutations in HIV-1.
Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2015)
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.
Peter M. Small;Robert W. Shafer;Philip C. Hopewell;Samir P. Singh.
The New England Journal of Medicine (1993)
2014 Update of the drug resistance mutations in HIV-1.
Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson.
Topics in antiviral medicine (2014)
Web resources for HIV type 1 genotypic-resistance test interpretation.
Tommy F. Liu;Robert W. Shafer.
Clinical Infectious Diseases (2006)
2019 update of the drug resistance mutations in HIV-1.
Annemarie M. Wensing;Vincent Calvez;Francesca Ceccherini-Silberstein;Charlotte Charpentier.
Topics in antiviral medicine (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Stanford University
Stanford University
Stanford University
Sheba Medical Center
University College London
Rega Institute for Medical Research
Stanford University
University of the Witwatersrand
University of California, San Diego
Stanford University
University of Toronto
MIT
Kyoto University
Case Western Reserve University
Stazione Zoologica Anton Dohrn
Medical University of South Carolina
The University of Texas MD Anderson Cancer Center
Leibniz Institute for Baltic Sea Research
McMaster University
Beijing Normal University
Pitié-Salpêtrière Hospital
Centre national de la recherche scientifique, CNRS
Boston University
Icahn School of Medicine at Mount Sinai
University of Nebraska Medical Center
European Southern Observatory